Session

OAB and nocturia

Poster Session 42

  • Location:
    Room Amsterdam, North Hall (Level 1)
  • Chairs:
     M.J. Drake, Bristol (GB)
     M. Oelke, Hanover (DE)
     A.J. Wein, Philadelphia (US)
  • Aims and objectives of this session

    OAB and nocturia remain important clinical challenges in an aging population. What are the new developments?

  • Poster viewing of 20 minutes. Presentations will take place on stage. Standard presentations are 2 minutes in length, followed by 2 minutes for discussion. Extended presentations (*) are 3 minutes in length, followed by 3 minutes for discussion.
561
Development of TANGO: A novel screening tool to identify co-existing causes of nocturia

By: Bower W.1, Rose G.2, Whishaw D.5, Ervin C.3, Khan F.2, Goldin J.4

Institutes: 1Melbourne Health, Dept. of Rehabilitation and Sub-Acute Community Services, Parkville, Australia, 2Melbourne Health, Dept. of Rehabilitation Services, Parkville, Australia, 3Melbourne Health, Dept. of Sub-Acute Community Services, Parkville, Australia, 4Melbourne Health, Dept. of Respiratory and Sleep Medicine, Parkville, Australia, 5Melbourne Health, Dept. of Aged Care Services and Urology, Parkville, Australia

562
Effects of imidafenacin on urine production, voided volume, and hours of undisturbed sleep in overactive bladder patients with nocturnal polyuria – post hoc analysis of two clinical trials

By: Yokoyama O.1, Takeda M.2, Gotoh M.3, Yoshida M.4, Kakizaki H.5, Takahashi S.6, Masumori N.7

Institutes: 1University of Fukui, Dept. of Urology, Fukui, Japan, 2University of Yamanashi, Dept. of Urology, Yamanashi, Japan, 3Nagoya University Graduate School of Medicine, Dept. of Urology, Nagoya, Japan, 4National Center For Geriatrics and Gerontology, Dept. of Urology, Obu, Japan, 5Asahikawa Medical University, Dept. of Renal and Urologic Surgery, Asahikawa, Japan, 6Nihon University School of Medicine, Dept. of Urology, Tokyo, Japan, 7Sapporo Medical University School of Medicine, Dept. of Urology, Sapporo, Japan

563
Influence of urinary calcium excretion on urinary symptoms such as nocturia

By: Tomohiro M.

Institutes: Nagasaki University, School of Medicine, Dept. of Urology, Nagasaki, Japan

564
Disruption of adaptation in bladder capacity for urine production rate during night time in aged men with nocturia: Analysis of the data of frequency volume chart

By: Kira S., Mitsui T., Miyamoto T., Ihara T., Nakagomi H., Sawada N., Takeda M.

Institutes: University of Yamanashi, Dept. of Urology, Chuo, Japan

565
Overnight ambulatory urodynamics findings in patients with nocturia and/or nocturnal enuresis

By: Solomon E., Ecclestone H., Duffy M., Malde S., Pakzad M., Hamid R., Greenwell T., Ockrim J.

Institutes: University College Hospital London, Dept. of Urology, London, United Kingdom

* 566
Reduction of nocturia in patients treated with C-PAP for obstructive sleep apnea syndrome

By: Degalliers S.1, De Vries P.1, Ewoldt T.2, Rahnama’i S.2

Institutes: 1Zuyderland Medical Center Heerlen, Dept. of Urology, Heerlen, The Netherlands, 2Maastricht University, Dept. of Urology, Maastricht, The Netherlands

567
Association between age and low risk of clean intermittent catheterisation with onabotulinumtoxinA in overactive bladder patients with accompanying improvements in urinary symptoms and quality of life

By: Drake M.1, Everaert K.2, Rovner E.3, Dmochowski R.4, Ginsberg D.5, Radomski S.6, Nitti V.7, Aboushwareb T.8, Chang C-T.9, Chapple C.R.10

Institutes: 1Bristol Urological Institute, Dept. of Urology, Bristol, United Kingdom, 2Ghent University Hospital, Dept. of Uro-Gynaecology, Ghent, Belgium, 3Medical University of South Carolina, Dept. of Urology, Charleston, United States of America, 4Vanderbilt University Medical Center, Dept. of Urologic Surgery, Nashville, United States of America, 5USC Institute of Urology, Dept. of Urology, Los Angeles, United States of America, 6University of Toronto, Dept. of Urology, Toronto, Canada, 7New York University, Dept. of Urology, New York, United States of America, 8Allergan Plc, Dept. of Urology, Irvine, California, United States of America, 9Allergan Plc, Dept. of Statistics, Bridgewater, United States of America, 10The Royal Hallamshire Hospital, Sheffield Teaching Hospitals, NHS Foundation Trust, Dept. of Urology, Sheffield, United Kingdom

568
Randomised crossover-controlled evaluation of simultanous-bilateral transcutaneous electrostimulation of nervus tibialis posterior during urodynamics

By: Fritsche H-M., Girtner F., Huber T., Mayr R., Burger M.

Institutes: University of Regensburg, Dept. of Urology, Regensburg, Germany

569
Development of an overactive bladder assessment tool: A potential alternative to the bladder diary

By: Kelleher C.1, Chapple C.2, Johnson N.3, Payne C.4, Homma Y.5, Hakimi Z.6, Siddiqui E.7, Kopp Z.3, Evans C.3

Institutes: 1Guy’s and St Thomas’ Hospitals, Dept. of Obstetrics and Gynecology, London, United Kingdom, 2Sheffield University, Dept. of Urology Research, Sheffield, United Kingdom, 3Endpoint Outcomes, Dept. of Outcomes Research, Boston, United States of America, 4Vista Urology & Pelvic Pain Partners, Dept. of Urology, San Jose, United States of America, 5University of Tokyo, Dept. of Urology, Tokyo, Japan, 6Astellas, Dept. of Medical Affairs, Leiden, The Netherlands, 7Astellas Pharma Europe Ltd, Dept. of Medical Affairs, Chertsey, United Kingdom

570
Long-term comparison of adherence to drug therapy in 1,917 patients with overactive bladder

By: Keishi K., Kanao K., Morinaga S., Muramatsu H., Saiki H., Kobayashi I., Nishikawa G., Kato Y., Watanabe M., Nakamura K., Sumitomo M.

Institutes: Aichi Medical University, Dept. of Urology, Nagakute, Japan

571
Three-months results of implant driven tibial nerve stimulation for the treatment of overactive bladder syndrome

By: Van Breda J., Martens F., Tromp J., Heesakkers J.

Institutes: Radboud University Medical Center, Dept. of Urology, Nijmegen, The Netherlands

572
New novel chronic tibial neuromodulation (CTNM) treatment option for OAB significantly improves urgency (UI)/urge urinary incontinence (UUI) and normalizes sleep patterns: Initial results

By: Sievert K-D.1, Milinovic L.2, Foditsch E.1, Dewachter S.4, Knupfer S.3, Kozomara M.3, Roggenkemp A.2, Kessler T.3

Institutes: 1Paracelsus Private Medical University of Salzburg, Dept. of Scitrecs, Salzburg, Austria, 2SALK, Dept. of Urology, Salzburg, Austria, 3Balgrist, Dept. of Neuro-Urology, Zurich, Switzerland, 4University of Antwerp, Dept. of Urology, Antwerp, Belgium

573
Do patients with OAB experience different bladder sensations?

By: Herrewegh A., Vrijens D., Marcelissen T., Van Koeveringe G.

Institutes: Maastricht Universitair Medisch Centrum+, Dept. of Urology, Maastricht, The Netherlands

574
Affective symptoms and quality of life in patients with voiding or storage dysfunction - results before and after sacral neuromodulation

By: Jairam R., Drossaerts J., Schilders I., Vrijens D., Van Koeveringe G., Van Kerrebroeck P.

Institutes: Maastricht UMC+, Dept. of Urology, Maastricht, The Netherlands